Yale Cancer Center

We are proud to share that Roy Herbst, MD, PhD,?Deputy Director and Chief of Medical Oncology for Yale Cancer Center and Smilow Cancer Hospital,?was awarded the prestigious?Ezra Greenspan Award by THE CHEMOTHERAPY FOUNDATION earlier this week at?its annual gala.? ? “I am incredibly honored to be recognized by a Foundation that has done so much to support patients and advance cancer treatment,” Dr. Herbst said. “We are truly at an amazing time of science, technology, and clinical brilliance—we can and must make progress.” The Ezra Greenspan Award?was?named in memory of the oncologist who founded The Chemotherapy+ Foundation in 1968 and was best known as?a pioneer of medical oncology, especially in the realm of combination chemotherapy for solid tumors. Congratulations, Dr. Herbst! https://lnkd.in/et7Pa9hj

We would like to welcome?Xuehong?Zhang, MBBS, MD, ScD, to the Cancer Prevention and Control Program.? ? Dr.?Zhang?is Professor and Assistant Dean of Research at Yale School of Nursing.??His research program is centered on digestive diseases and cancers, with a focus on liver-related conditions. His broad research interests encompass diet, lifestyle, obesity, environmental risk factors, biomarkers, health disparities, early detection, diagnosis, and global health.

Alessandro Santin, MD, Co-Chief, Section of Gynecologic Oncology joined the?International Journal of Gynecologic Cancer?podcast to discuss the TROPiCS-03 trial and its encouraging results in patients with recurrent?endometrial cancer. ? In the TROPiCS-03 trial, Sacituzumab Govitecan demonstrated encouraging clinical activity in patients with recurrent?endometrial cancer in progression after chemotherapy and immune check point inhibitors.?Additionally, the?toxicity profile for Sacituzumab Govitecan was found to be manageable with only 5% of patients discontinuing treatment due to treatment-related adverse events. TROP-2 protein was expressed in more 90% of the patients with endometrial cancer patients enrolled in the trial, and showed limited correlation with efficacy to Sacituzumab Govitecan. ? https://lnkd.in/eYgyf9Bx

We are pleased to welcome?Lorraine Colón Cartagena, MD, to our membership.? ? As an Assistant Professor of Pathology, Dr. Colón-Cartagena devotes her research to?further understanding the behavior and histologic features of tumors of the breast. She joins the Genomics, Genetics, and Epigenetics Program. Yale Pathology

Roy Herbst, MD, PhD, Deputy Director and Chief of Medical Oncology for Yale Cancer Center and Smilow Cancer Hospital, will present the Greenspan Lecture at the Physicians' Education Resource?, LLC (PER?) 42nd?Annual CFS (Chemotherapy Foundation Symposium): Innovative Cancer Therapy for Tomorrow?, Thursday, November 14 at 1:40pm EST. Dr. Herbst will present “Twenty Years of Progress in the Treatment of Non-Small Cell Lung Cancer: Targeted Therapy, Immunotherapy, and the Emergence of Treatment for Early Disease.” Learn more:?https://bit.ly/4eh53oU

Congratulations to Raghav Sundar MBBS, PhD, recipient of a $100,000 seed grant from?the Gastric Cancer Foundation for a research project aimed at understanding the differences between early-onset and average-onset gastric cancer. Along with Wenyi Luo, MD, PhD, Yale Pathology, Dr. Sundar’s first goal is to define how the expression of eight specific biomarkers in gastric tumors differs between early-onset and average-onset cancer. https://lnkd.in/ep_eDMM6

We are pleased to congratulate Daniel Boffa, MD, on his appointment as Vice-Chair of the American College of Surgeons Commission on Cancer (CoC). In this role, Dr. Boffa will collaborate closely with and provide support to the CoC Chair, including representing the program in various capacities.? ? As Professor of Thoracic Surgery, Dr. Boffa?specializes in surgery for esophageal and lung cancer.?He focuses his clinical research on identifying the most effective way of treating patients with cancer, particularly those with advanced lung cancer, as well as quality of care across different hospital networks.? ? Congratulations, Dr. Boffa! ? https://lnkd.in/eQmUUZ7x

The 19th?Annual New York Lung Cancers Symposium will be taking place on Saturday, November 16 from 5:45pm to 6:45pm. Hosted by?Physicians' Education Resource?, LLC (PER?), attendees will gain a comprehensive overview of multidisciplinary lung cancer treatment and lung cancer therapy, including the roles that surgery, radiology, pulmonology, and pathology play to ensure the most accurate diagnosis of lung cancers.? ? Among the presenters are Yale Cancer Center faculty and members of the Center for Thoracic Cancers, Roy Herbst, MD, PhD; Anne Chiang, MD, PhD, and So Yeon Kim, MD, as well as colleague, Sanja Dacic, MD, PhD, MSc, from Yale Pathology.? ? Register today for free using code?NYLSAP:?https://lnkd.in/emYcjjSm

We are pleased to welcome?Dr. Fed?Ghali to our Cancer Prevention and Control Program. Dr.?Ghali?is a urologic oncologist who specializes in treating cancers of the bladder, ureter, kidney, and testis. His research is focused on clinical trial design and biomarker development.

We had a terrific turnout for the first Yale Cancer Center National Clinical Trials Network (NCTN) Summit on Friday, October 25, with?nearly 60?attendees.? Anne Chiang, MD, PhD, who serves as PI for our NCTN LAPS (Lead Academic Participating Sites) grant welcomed all and introduced speaker, Roy Herbst, MD, PhD, who gave the Keynote address on "The Impact of Cooperative Group Science: From Public to Personal."? ? An interactive panel session followed, "How to Engage in the Cooperative Groups," with faculty Barbara Burtness, MD, (ECOG), Maryam Lustberg, MD, MPH, (ALLIANCE), Kert Sabbath, MD (ALLIANCE),?Henry S. Park, MD, MPH, (NRG), Roy Herbst, MD, PhD, (SWOG) and moderated by Anne Chiang, MD, PhD, (SWOG). Finally, all participated in breakout groups on Clinical Trials, Translational Studies, Mentoring/Training and Community Outreach facilitated by Drs. Stacey Stein, MD/Kert Sabbath, MD, Lajos Pusztai, MD, DPhil/Barbara Burtness, MD, Sarah Goldberg, MD, MPH/Maryam Lustberg, MD, MPH, and Jacquelyne Gaddy, MD, MSCR, MSc/Jessica Lewis, Ph.D., respectively.??